Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Cancer Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global cancer biomarkers market reached a value of US$ 21.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 47.66 Billion by 2027, exhibiting a growth rate (CAGR) of 13.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Cancer biomarkers are biological molecules that indicate the presence of cancerous cells in the blood, tissues or other fluids of the body. They can be produced by the cancer cell itself or by other tissues in the body in response to cancer. Some common forms of cancer include breast, prostate, cervical, lung, and colorectal cancer. They are widely used for diagnosing the disease, monitoring their progression, distinguishing between invasive and non-invasive tumors, predicting the chances of recurrences and recording therapeutic treatment efficacy. Enzymes, proteins, nucleic acids, genes, specific cells. and peptides are some of the common types of biomarkers. As a result, they are widely used as prognostics, surrogate endpoints, diagnostics, and personalized medicines.

Cancer Biomarkers Market Trends:

The increasing prevalence of cancer across the globe is creating a positive outlook for the market. Biomarkers are widely used for early cancer detection and during treatment and management to accurately and reliably predict outcomes. In line with this, the increasing incidences of lung cancer due to the upsurge in pollution levels, smoking trends and poor ingestion habits is augmenting the market growth. Moreover, various technological advancements in genetic biomarker discovery, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), gene expression profiling (microarray), and the artificial inelegance (AI) that assist in predicting the recurrence of cancer after treatment, are providing an impetus to the market growth. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early diagnosis and the significant shift toward personalized medicine for cancer treatment due to the lack of standard diagnosis is favoring the market growth. Other factors, including the significant growth in the healthcare industry, extensive research and development (R&D) activities and the implementation of various government initiatives for enhancing the drug development processes, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer biomarkers market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on profiling technology, biomolecule, cancer type, application and end user.

Breakup by Profiling Technology:

  • Omic Technologies
  • Imaging Technologies
  • Immunoassays
  • Cytogenetics
     

Breakup by Biomolecule:

  • Genetic Biomarkers
  • Protein Biomarkers
  • Glyco-Biomarkers
     

Breakup by Cancer Type:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Others
     

Breakup by Application:

  • Diagnostics
  • Prognostics
  • Risk Assessment
  • Drug Discovery and Development
  • Others
     

Breakup by End User:

  • Hospitals
  • Academic and Research Institutions
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Illumina Inc., Qiagen N.V., Sino Biological Inc. and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Profiling Technology, Biomolecule, Cancer Type, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Illumina Inc., Qiagen N.V., Sino Biological Inc. and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global cancer biomarkers market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cancer biomarkers market?
  • What are the key regional markets?
  • What is the breakup of the market based on the profiling technology?
  • What is the breakup of the market based on the biomolecule?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cancer biomarkers market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Cancer Biomarkers Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Profiling Technology
    6.1    Omic Technologies
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Imaging Technologies
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Immunoassays
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Cytogenetics
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Biomolecule
    7.1    Genetic Biomarkers
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Protein Biomarkers
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Glyco-Biomarkers
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Cancer Type
    8.1    Breast Cancer
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Lung Cancer
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Colorectal Cancer
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Prostate Cancer
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Stomach Cancer
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Others
        8.6.1 Market Trends
        8.6.2 Market Forecast
9    Market Breakup by Application
    9.1    Diagnostics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Prognostics
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Risk Assessment
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Drug Discovery and Development
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10    Market Breakup by End User
    10.1    Hospitals
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Academic and Research Institutions
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Ambulatory Surgical Centers
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4    Diagnostic Laboratories
        10.4.1 Market Trends
        10.4.2 Market Forecast
    10.5    Others
        10.5.1 Market Trends
        10.5.2 Market Forecast
11    Market Breakup by Region
    11.1    North America
        11.1.1 United States
           11.1.1.1 Market Trends
           11.1.1.2 Market Forecast
        11.1.2 Canada
           11.1.2.1 Market Trends
           11.1.2.2 Market Forecast
    11.2    Asia-Pacific
        11.2.1 China
           11.2.1.1 Market Trends
           11.2.1.2 Market Forecast
        11.2.2 Japan
           11.2.2.1 Market Trends
           11.2.2.2 Market Forecast
        11.2.3 India
           11.2.3.1 Market Trends
           11.2.3.2 Market Forecast
        11.2.4 South Korea
           11.2.4.1 Market Trends
           11.2.4.2 Market Forecast
        11.2.5 Australia
           11.2.5.1 Market Trends
           11.2.5.2 Market Forecast
        11.2.6 Indonesia
           11.2.6.1 Market Trends
           11.2.6.2 Market Forecast
        11.2.7 Others
           11.2.7.1 Market Trends
           11.2.7.2 Market Forecast
    11.3    Europe
        11.3.1 Germany
           11.3.1.1 Market Trends
           11.3.1.2 Market Forecast
        11.3.2 France
           11.3.2.1 Market Trends
           11.3.2.2 Market Forecast
        11.3.3 United Kingdom
           11.3.3.1 Market Trends
           11.3.3.2 Market Forecast
        11.3.4 Italy
           11.3.4.1 Market Trends
           11.3.4.2 Market Forecast
        11.3.5 Spain
           11.3.5.1 Market Trends
           11.3.5.2 Market Forecast
        11.3.6 Russia
           11.3.6.1 Market Trends
           11.3.6.2 Market Forecast
        11.3.7 Others
           11.3.7.1 Market Trends
           11.3.7.2 Market Forecast
    11.4    Latin America
        11.4.1 Brazil
           11.4.1.1 Market Trends
           11.4.1.2 Market Forecast
        11.4.2 Mexico
           11.4.2.1 Market Trends
           11.4.2.2 Market Forecast
        11.4.3 Others
           11.4.3.1 Market Trends
           11.4.3.2 Market Forecast
    11.5    Middle East and Africa
        11.5.1 Market Trends
        11.5.2 Market Breakup by Country
        11.5.3 Market Forecast
12    SWOT Analysis
    12.1    Overview
    12.2    Strengths
    12.3    Weaknesses
    12.4    Opportunities
    12.5    Threats
13    Value Chain Analysis
14    Porters Five Forces Analysis

    14.1    Overview
    14.2    Bargaining Power of Buyers
    14.3    Bargaining Power of Suppliers
    14.4    Degree of Competition
    14.5    Threat of New Entrants
    14.6    Threat of Substitutes
15    Price Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    Abbott Laboratories
           16.3.1.1 Company Overview
           16.3.1.2 Product Portfolio
           16.3.1.3 Financials
           16.3.1.4 SWOT Analysis
        16.3.2    Agilent Technologies Inc.
           16.3.2.1 Company Overview
           16.3.2.2 Product Portfolio
           16.3.2.3 Financials
           16.3.2.4 SWOT Analysis
        16.3.3    Becton Dickinson and Company
           16.3.3.1 Company Overview
           16.3.3.2 Product Portfolio
           16.3.3.3 Financials
           16.3.3.4 SWOT Analysis
        16.3.4    bioMérieux SA
           16.3.4.1 Company Overview
           16.3.4.2 Product Portfolio
           16.3.4.3 Financials
           16.3.4.4 SWOT Analysis
        16.3.5    Danaher Corporation
           16.3.5.1 Company Overview
           16.3.5.2 Product Portfolio
           16.3.5.3 Financials
           16.3.5.4 SWOT Analysis
        16.3.6    F. Hoffmann-La Roche AG
           16.3.6.1 Company Overview
           16.3.6.2 Product Portfolio
           16.3.6.3 SWOT Analysis
        16.3.7    General Electric Company
           16.3.7.1 Company Overview
           16.3.7.2 Product Portfolio
           16.3.7.3 Financials
           16.3.7.4 SWOT Analysis
        16.3.8    Illumina Inc.
           16.3.8.1 Company Overview
           16.3.8.2 Product Portfolio
           16.3.8.3 Financials
           16.3.8.4 SWOT Analysis
        16.3.9    Qiagen N.V.
           16.3.9.1 Company Overview
           16.3.9.2 Product Portfolio
           16.3.9.3 Financials
           16.3.9.4 SWOT Analysis
        16.3.10    Sino Biological Inc.
           16.3.10.1 Company Overview
           16.3.10.2 Product Portfolio
        16.3.11    Thermo Fisher Scientific Inc.
           16.3.11.1 Company Overview
           16.3.11.2 Product Portfolio
           16.3.11.3 Financials
           16.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Cancer Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Cancer Biomarkers Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cancer Biomarkers Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Cancer Biomarkers Market: Breakup by Profiling Technology (in %), 2021
Figure 5: Global: Cancer Biomarkers Market: Breakup by Biomolecule (in %), 2021
Figure 6: Global: Cancer Biomarkers Market: Breakup by Cancer Type (in %), 2021
Figure 7: Global: Cancer Biomarkers Market: Breakup by Application (in %), 2021
Figure 8: Global: Cancer Biomarkers Market: Breakup by End User (in %), 2021
Figure 9: Global: Cancer Biomarkers Market: Breakup by Region (in %), 2021
Figure 10: Global: Cancer Biomarkers (Omic Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Cancer Biomarkers (Omic Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Cancer Biomarkers (Imaging Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Cancer Biomarkers (Imaging Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Cancer Biomarkers (Immunoassays) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Cancer Biomarkers (Immunoassays) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Cancer Biomarkers (Cytogenetics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Cancer Biomarkers (Cytogenetics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Cancer Biomarkers (Genetic Biomarkers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Cancer Biomarkers (Genetic Biomarkers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Cancer Biomarkers (Protein Biomarkers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Cancer Biomarkers (Protein Biomarkers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Cancer Biomarkers (Glyco-Biomarkers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Cancer Biomarkers (Glyco-Biomarkers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Cancer Biomarkers (Breast Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Cancer Biomarkers (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Cancer Biomarkers (Lung Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Cancer Biomarkers (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Cancer Biomarkers (Colorectal Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Cancer Biomarkers (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Cancer Biomarkers (Prostate Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Cancer Biomarkers (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Cancer Biomarkers (Stomach Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Cancer Biomarkers (Stomach Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Cancer Biomarkers (Other Cancer Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Cancer Biomarkers (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Cancer Biomarkers (Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Cancer Biomarkers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Cancer Biomarkers (Prognostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Cancer Biomarkers (Prognostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Cancer Biomarkers (Risk Assessment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Cancer Biomarkers (Risk Assessment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: Cancer Biomarkers (Drug Discovery and Development) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: Cancer Biomarkers (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Global: Cancer Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Global: Cancer Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Global: Cancer Biomarkers (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Global: Cancer Biomarkers (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Global: Cancer Biomarkers (Academic and Research Institutions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Global: Cancer Biomarkers (Academic and Research Institutions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Global: Cancer Biomarkers (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Global: Cancer Biomarkers (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Global: Cancer Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Global: Cancer Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: North America: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: North America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United States: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United States: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Canada: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Canada: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Asia-Pacific: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Asia-Pacific: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: China: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: China: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Japan: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Japan: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: India: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: India: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: South Korea: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: South Korea: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Australia: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Australia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Indonesia: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Indonesia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Europe: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Europe: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Germany: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Germany: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: France: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: France: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: United Kingdom: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: United Kingdom: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Italy: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Italy: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Spain: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: Spain: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Russia: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 91: Russia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 93: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 94: Latin America: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 95: Latin America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Brazil: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 97: Brazil: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 98: Mexico: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 99: Mexico: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 100: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 101: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 102: Middle East and Africa: Cancer Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 103: Middle East and Africa: Cancer Biomarkers Market: Breakup by Country (in %), 2021
Figure 104: Middle East and Africa: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 105: Global: Cancer Biomarkers Industry: SWOT Analysis
Figure 106: Global: Cancer Biomarkers Industry: Value Chain Analysis
Figure 107: Global: Cancer Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer Biomarkers Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cancer Biomarkers Market Forecast: Breakup by Profiling Technology (in Million US$), 2022-2027
Table 3: Global: Cancer Biomarkers Market Forecast: Breakup by Biomolecule (in Million US$), 2022-2027
Table 4: Global: Cancer Biomarkers Market Forecast: Breakup by Cancer Type (in Million US$), 2022-2027
Table 5: Global: Cancer Biomarkers Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Cancer Biomarkers Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 7: Global: Cancer Biomarkers Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 8: Global: Cancer Biomarkers Market: Competitive Structure
Table 9: Global: Cancer Biomarkers Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4